ID   C3-44
AC   CVCL_G700
SY   C3-44/MO; C-344; C344
DR   ChEMBL-Cells; CHEMBL3307921
DR   ChEMBL-Targets; CHEMBL614371
DR   PubChem_Cell_line; CVCL_G700
DR   Wikidata; Q54808141
RX   PubMed=6095307;
RX   PubMed=9516127;
CC   Virology: Persistently infected with HTLV-2 isolate Mo (PubMed=6095307).
CC   Transformant: NCBI_TaxID; 11909; Human T-lymphotropic virus 2 (HTLV-2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
RX   PubMed=6095307; DOI=10.1073/pnas.81.23.7579; PMCID=PMC392190;
RA   Lee T.-H., Coligan J.E., McLane M.F., Sodroski J.G., Popovic M.,
RA   Wong-Staal F., Gallo R.C., Haseltine W.A., Essex M.;
RT   "Serological cross-reactivity between envelope gene products of type I
RT   and type II human T-cell leukemia virus.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:7579-7583(1984).
//
RX   PubMed=9516127; DOI=10.1182/blood.V91.7.2296;
RA   Casoli C., Re M.C., Monari P., Furlini G., Tosi G., Gradozzi C.,
RA   Dall'Aglio P.P., Bertazzoni U., Accolla R.S.;
RT   "Human T-cell leukemia virus type II directly acts on CD34+
RT   hematopoietic precursors by increasing their survival potential.
RT   envelope-associated HLA class II molecules reverse this effect.";
RL   Blood 91:2296-2304(1998).
//